Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus

Carcinogenesis

Volumn 19, Issue 4, 1998, Pages 667-672

  Smith, Theresa J ^a   Liao, Anita ^a   Wang, Li Dong ^a,b   Yang, Guang Yu ^a   Starcic, Sandra ^a   Philbert, Martin A ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COUMARIN DERIVATIVE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; N METHYL DEXTRO ASPARTIC ACID; NITROSAMINE; NITROSONORNICOTINE; OXYGENASE; PEROXIDASE; TROLEANDOMYCIN;

ARTICLE; CHINA; CONTROLLED STUDY; ESOPHAGUS CANCER; HUMAN; HUMAN TISSUE; MICROSOME; PRIORITY JOURNAL; SMOKING; UNITED STATES; XENOBIOTIC METABOLISM;

ADULT; DIMETHYLNITROSAMINE; ENZYME INHIBITORS; ENZYMES; ESOPHAGUS; FEMALE; HUMANS; MALE; MICROSOMES; MIDDLE AGED; NITROSAMINES; XENOBIOTICS;

EID: 0031867196     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.4.667     Document Type: Article

References (57)

1. Day,N.E. and Varghese,C. (1994) Oesophageal cancer. Cancer Surv., 19/ 20, 43-54.
2. Parkin,D.M., Laara,E. and Muir,C.S. (1988) Estimates of the worldwide frequency of 16 major cancers in 1980s. Int. J. Cancer, 41, 184-197.
3. Cook-Mazaffari,P. (1979) The epidemiology of cancer of the esophagus. Nutr. Cancer, 1, 51-60.
4. Warwick,G.P. (1973) Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv. Cancer Res., 17, 81-229.
5. Yang,C.S. (1980) Research on esophageal cancer in China: a review. Cancer Res., 40, 2633-2644.
6. Van Rensburg,S.J. (1981) Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. J. Natl Cancer Inst., 67, 243-251.
7. Yang,C.S. (1982) Nitrosamines and other etiological factors in the esophageal cancer in northern China. In Magee,P.N. (ed.) Banbury Report 12: Nitrosamines anil Human Cancer. Cold Spring Harbor Laboratory, New York, pp. 487-501.
8. Mirvish,S.S. (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett., 93. 17-48.
9. Magee,P.N. and Bames,J.M. (1967) Carcinogenic nitroso compounds. Adv. Cancer Res., 10, 163-246.
10. Magee,P.N. (1989) The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv., 8, 207-239.
11. Druckrey,H., Preussmann,R., Ivankovic,S. and Schmahl,D. (1967) Organotrope carcinogene Wirkung bei 65 verschiedenen N-nitrosoverbindungen an BD-12 Ratten. Z. Krebsforsch., 69, 103-201.
12. 6-Methylguanine levels and histopathological changes in the rat esophagus and liver following single and repeated administration of N-nitrosomethylbenzylamine. Carcinogenesis, 17, 1135-1140.
13. Dirsch,O.R., Koenigsmann,M., Ludeke,B.I., Scherer,E. and Kleihues,P. (1990) Bioactivation of N-nitrosomethylbenzylamine and N-nitrosomethylamylamine in oesophageal papillomas. Carcinogenesis, 11, 1583-1586.
14. 6-Methyldeoxyguanosine in esophageal DNA among individuals at high risk of esophageal cancer. Int. J. Cancer, 36, 661-665.
15. Hecht,S.S. (1994) Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab. Rev., 26, 373-390.
16. Hoffmann,D. and Hecht,S.S. (1985) Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res., 45, 935-944.
17. Bartsch,H. and Montesano,R. (1984) Relevance of nitrosamines to human cancer. Carcinogenesis, 5, 1381-1393.
18. Adams,J.D., O'Mara-Adams,K.J. and Hoffmann,D. (1987) Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis, 8, 729-731.
19. Magee,P.N. and Barnes,J.M. (1956) The production of malignant primary hepatic tumors in the rat by feeding dimethylnitrosamine. Br. J. Cancer, 10, 114-122.
20. Trushin,N., Rivenson,A. and Hecht,S.S. (1994) Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis hy tobacco-specific nitrosamines. Cancer Res., 54, 1205-1211.
21. 6-methylguanine. Cancer Res., 53, 2780-2785.
22. Hecht,S.S., Carmella,S.G., Foiles,P.G., Murphy,S.E. and Peterson,L.A. (1993) Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. Environ. Health Perspect., 99, 57-63.
23. Hecht,S.S., Jordan,K.G., Choi,C.-I. and Trushin,N. (1990) Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis, 11, 1017-1020.
24. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res., 51, 5557-5564.
25. Murphy,S.E. and Spina,D.A. (1994) Evidence for a high-affinity enzyme in rat esophageal microsomes which α-hydroxylates N'-nitrosonornicotine. Carcinogenesis, 15, 2709-2713.
26. Staretz,M.E., Murphy,S.E., Patten,C.J., Nunes,M.G., Koehl,W., Amin,S., Koenig,L.A., Guengerich,F.P. and Hecht,S.S. (1997) Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and N'-nitrosonornicotine in human hepatic microsomes. Drug Metab. Disp., 25, 154-162.
27. Patten,C.J., Smith,T.J., Friesen,M.J., Tynes,R.E., Yang,C.S. and Murphy,S.E. (1997) Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis, 18, 1623-1630.
28. Smith,T.J., Guo,Z., Gonzalez,F.J., Guengerich,F.P., Stoner,G.D. and Yang,C.S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res., 52, 1757-1763.
29. Smith,T.J., Stoner,G.D. and Yang,C.S. (1995) Activation of 4-(methylnitrosamino)-1-(3pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res., 55, 5566-5573.
30. Yang,C.S., Smith,T.J., Hong,J.-Y. and Zhou,S. (1994) Kinetics and enzymes involved in the metabolism of nitrosamines. In Loeppky,R.N. and Michejda,C.J. (eds) The Chemistry and Biochemistry of Nitrosamines and Related N-Nitroso Compounds, 553. ACS Symposium, Washington, DC, pp. 169-178.
31. Pickett,C.B. and Lu,A.Y.H. (1989) Glutathione S-transferases: gene structure, regulation, and biological function. Ann. Rev. Biochem., 58, 743-764.
32. Mannervik,B., Alin,P., Guthenberg,C., Jensson,H., Tahir,M.K., Warholrn,M. and Jornvall,H. (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl Acad. Sci. USA, 82, 7202-7206.
33. Daniel,V. (1993) Glutathione S-transferases: gene structure and regulation of expression. CRC Crit. Rev. Biochem. Mol. Biol., 28, 173-207.
34. Seidegard,J., Vorachek,W.R., Pero,R.W. and Pearson,W.R. (1988) Hereditary differences in the expression of human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion. Proc. Natl Acad. Sci. USA, 85, 7293-7297.
35. Pemble,S., Schroeder,K.R., Spencer,S.R., Meyer,D.J., Hallier,E., Bolt,H.M., Ketterer,B. and Taylor,J.B. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300, 271-276.
36. Nelson,H.H., Wiencke,J.K., Christiani,D.C. et al. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis, 16, 1243-1245.
37. Campbell,J.A.H., Corrigall,A.V., Guy,A. and Kirsch,P.E. (1991) Immunohistologic localization of alpha, mu and pi class glutathione S-transferases in human tissues. Cancer, 67, 1608-1613.
38. Nakajima,T., Wang,R.-S., Nimura,Y., Pin,Y.-M., He,M., Vainio,H., Murayama,N., Aoyama,T. and lida,F. (1996) Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis, 17, 1477-1481.
39. Sasano,H., Miuazaki,S., Shiga,K., Goukon,Y., Nishihira,T. and Nagura,H. (1993) Glutathione S-transferase in human esophageal carcinoma. Anticancer Res., 13, 363-368.
40. Autrup,H. (1982) Carcinogen metabolism in human tissues and cells. Drug Metab. Rev., 13, 603-646.
41. Koga,N., Inskeep.P.B., Harris,T.M. and Guengerich,F.P. (1986) S-[2-N7-Guanyl ethyl]glutathione, the major DNA adduct formed from 1,2-dibromoethane. Biochemistry, 25, 2192-2198.
42. MacFarland,R.T. Gandolfi,A.J. and Sipes,I.G. (1984) Extra-hepatic GSH-dependent metabolism of 1,2-dibromoethane (DBE) and 1,2-dibromo-3-chloropropane (DBCP) in the rat and mouse. Drug Chem. Toxicol., 7, 213-227.
43. Smith,T.J., Guo,Z.-Y., Thomas,P.E., Chung,F.-L., Morse,M.A., Eklind,K. and Yang,C.S. (1990) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res., 50, 6817-6822.
44. Wang,M.-H., Wade,D., Chen,L., White,S. and Yang,C.S. (1995) Probing the active sites of rat and human cytochrome P450 2E1 with alcohols and carboxylic acids. Arch. Biochem. Biophys., 317, 299-304.
45. Phillips,A.H. and Langdon,R.G. (1962) Hepatic triphosphopyridine nucleotide cytochrome c reductase: isolation, characterization, and kinetic studies. J. Biol. Chem., 237, 2652-2660.
46. Yun,C.-H., Shimada,T. and Guengerich,F.P. (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol., 40, 679-685.
47. Hollander,P.M. and Ernster,L. (1975) Studies on the reaction and mechanism of DTdiaphorase: action of dead-end inhibitors and effects of phospholipid. Arch. Biochem. Biophys., 169, 560-567.
48. Benson,A.N., Talalay.P., Keen,J.H. and Jakoby,W.B. (1977) Relationship between the soluble glutathione-dependent delta 5-3 keto steroid isomerase and the glutathione S-transferases of the liver. Proc. Natl Acad. Sci. USA, 74, 158-162.
49. Wang,L.D., Shi,S.T., Zhou,Q., Goldstein,S., Hong,J.-Y, Shao,P., Qiu,S.-L. and Yang,C.S. (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int. J. Cancer, 59, 514-519.
50. Castonguay,A., Stoner,G.D., Schut,H.A. and Hecht,S.S. (1983) Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc. Natl Acad. Sci. USA, 80, 6694-6697.
51. Chakradeo,P.P., Nair,J. and Bhide,S.V. (1995) Metabolism of N'-nitrosonornicotine by adult and fetal human oesophageal cultures. Cell Biol. Int., 19, 53-58.
52. Murphy,S.E., Heiblum,R. and Trushin,N. (1990) Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. Cancer Res., 50, 4685-4691.
53. Murray,G.I., Shaw,D., Weaver,R.J., McKay,J.A., Ewen,S.W.B., Melvin,W.T. and Burke,M.D. (1994) Cytochrome P450 expression in oesophageal cancer. Gut, 35, 599-603.
54. McKinnon,R.A., Burgess,W.M., Hall,P.d.l.M., Roberts-Thomson,S.J., Gonzalez,F.J. and McManus,M.E. (1995) Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut. 36, 259-267.
55. Daly,A.K., Cholerton,S., Gregory,W. and Idle,J.R. (1993) Metabolic polymorphisms. Pharmac. Ther., 57, 129-160.
56. Traver,R.D., Siegel.D., Beall,H.D., Phillips,R.M., Gibson,N.W., Franklin,W.A. and Ross,D. (1997) Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). Br. J. Cancer, 75, 69-75.
57. Wiencke,J.K., Spitz,M.R., McMillan,A. and Kelsey,K.T. (1997) Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Cancer Epidemiol. Biomark. Prev., 6, 87-92.